Skip to main content
Clinical Trials/IRCT20160827029535N9
IRCT20160827029535N9
Not yet recruiting
Phase 2

The comparison of the efficacy of two different doses of lansoprazole in the treatment of neonatal gastro esophageal reflux disease refractory to conservative therapy

Tehran University of Medical Sciences0 sites120 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Gastroesophageal Reflux.
Sponsor
Tehran University of Medical Sciences
Enrollment
120
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Healthy term neonates aged 1–30days with GERD not responding to conservative therapy (including anti\-reflux positioning, milk thickening and feeding with lower volume of milk and shorter interval).

Exclusion Criteria

  • 1\-Neonates with any underlying diseases, including anomalies or gastrointestinal obstruction, neurological disorders, sepsis, NEC, etc.2\-Using any sedative , relaxant or anticonvulsive medications .3\-History of ventilation therapy.

Outcomes

Primary Outcomes

Not specified

Similar Trials